These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 12714026)

  • 1. Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.
    Tonstad S; Farsang C; Klaene G; Lewis K; Manolis A; Perruchoud AP; Silagy C; van Spiegel PI; Astbury C; Hider A; Sweet R
    Eur Heart J; 2003 May; 24(10):946-55. PubMed ID: 12714026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
    Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR;
    JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.
    Tønnesen P; Tonstad S; Hjalmarson A; Lebargy F; Van Spiegel PI; Hider A; Sweet R; Townsend J
    J Intern Med; 2003 Aug; 254(2):184-92. PubMed ID: 12859700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bupropion for smoking cessation in African American light smokers: a randomized controlled trial.
    Cox LS; Nollen NL; Mayo MS; Choi WS; Faseru B; Benowitz NL; Tyndale RF; Okuyemi KS; Ahluwalia JS
    J Natl Cancer Inst; 2012 Feb; 104(4):290-8. PubMed ID: 22282543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial.
    Tashkin D; Kanner R; Bailey W; Buist S; Anderson P; Nides M; Gonzales D; Dozier G; Patel MK; Jamerson B
    Lancet; 2001 May; 357(9268):1571-5. PubMed ID: 11377644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial.
    Ahluwalia JS; Harris KJ; Catley D; Okuyemi KS; Mayo MS
    JAMA; 2002 Jul 24-31; 288(4):468-74. PubMed ID: 12132977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
    Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
    Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study.
    Gonzales DH; Nides MA; Ferry LH; Kustra RP; Jamerson BD; Segall N; Herrero LA; Krishen A; Sweeney A; Buaron K; Metz A
    Clin Pharmacol Ther; 2001 Jun; 69(6):438-44. PubMed ID: 11406741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of cessation in African American light smokers enrolled in a bupropion clinical trial.
    Faseru B; Nollen NL; Mayo MS; Krebill R; Choi WS; Benowitz NL; Tyndale RF; Okuyemi KS; Ahluwalia JS; Sanderson Cox L
    Addict Behav; 2013 Mar; 38(3):1796-803. PubMed ID: 23254230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation.
    Johnston JA; Fiedler-Kelly J; Glover ED; Sachs DP; Grasela TH; DeVeaugh-Geiss J
    Nicotine Tob Res; 2001 May; 3(2):131-40. PubMed ID: 11403727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees.
    Dalsgareth OJ; Hansen NC; Søes-Petersen U; Evald T; Høegholm A; Barber J; Vestbo J
    Nicotine Tob Res; 2004 Feb; 6(1):55-61. PubMed ID: 14982688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bupropion Slow Release vs Placebo With Adaptive Incentives for Cocaine Use Disorder in Persons Receiving Methadone for Opioid Use Disorder: A Randomized Clinical Trial.
    Ware OD; Sweeney MM; Cunningham C; Umbricht A; Stitzer M; Dunn KE
    JAMA Netw Open; 2023 Mar; 6(3):e232278. PubMed ID: 36920397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in health-related quality of life with smoking cessation treatment.
    Hays JT; Croghan IT; Baker CL; Cappelleri JC; Bushmakin AG
    Eur J Public Health; 2012 Apr; 22(2):224-9. PubMed ID: 20884658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupropion for smoking cessation : predictors of successful outcome.
    Dale LC; Glover ED; Sachs DP; Schroeder DR; Offord KP; Croghan IT; Hurt RD
    Chest; 2001 May; 119(5):1357-64. PubMed ID: 11348939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bupropion SR vs placebo for smoking cessation in health care professionals.
    Zellweger JP; Boelcskei PL; Carrozzi L; Sepper R; Sweet R; Hider AZ
    Am J Health Behav; 2005; 29(3):240-9. PubMed ID: 15899687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of sustained-release bupropion in specific patient populations for smoking cessation.
    Tonstad S
    Drugs; 2002; 62 Suppl 2():37-43. PubMed ID: 12109934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.
    Weiner E; Ball MP; Buchholz AS; Gold JM; Evins AE; McMahon RP; Buchanan RW
    J Clin Psychiatry; 2012 Jan; 73(1):95-102. PubMed ID: 21535998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of bupropion sustained-release on cigarette craving after smoking cessation.
    Durcan MJ; Deener G; White J; Johnston JA; Gonzales D; Niaura R; Rigotti N; Sachs DP
    Clin Ther; 2002 Apr; 24(4):540-51. PubMed ID: 12017399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.